| Mutations in the deubiquitinase gene USP8 cause Cushing's disease M Reincke, S Sbiera, A Hayakawa, M Theodoropoulou, A Osswald, ... Nature genetics 47 (1), 31-38, 2015 | 343 | 2015 |
| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliövaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 307 | 2010 |
| Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome F Beuschlein, M Fassnacht, G Assié, D Calebiro, CA Stratakis, A Osswald, ... New England Journal of Medicine 370 (11), 1019-1028, 2014 | 305 | 2014 |
| Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study M Fassnacht, A Berruti, E Baudin, MJ Demeure, J Gilbert, H Haak, ... The lancet oncology 16 (4), 426-435, 2015 | 235 | 2015 |
| Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection F Beuschlein, J Weigel, W Saeger, M Kroiss, V Wild, F Daffara, R Libé, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), 841-849, 2015 | 209 | 2015 |
| Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels M Arosio, CL Ronchi, C Gebbia, V Cappiello, P Beck-Peccoz, M Peracchi The Journal of Clinical Endocrinology & Metabolism 88 (2), 701-704, 2003 | 199 | 2003 |
| High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. MA Tichomirowa, A Barlier, A Daly, M Jaffrain-Rea, C Ronchi, M Yaneva, ... European Journal of Endocrinology 165 (4), 509-15, 2011 | 146 | 2011 |
| Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells S Sbiera, E Leich, G Liebisch, I Sbiera, A Schirbel, L Wiemer, S Matysik, ... Endocrinology 156 (11), 3895-3908, 2015 | 142 | 2015 |
| Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study R Libé, I Borget, CL Ronchi, B Zaggia, M Kroiss, T Kerkhofs, J Bertherat, ... Annals of Oncology 26 (10), 2119-2125, 2015 | 134 | 2015 |
| Effects of modified sham feeding on ghrelin levels in healthy human subjects M Arosio, CL Ronchi, P Beck-Peccoz, C Gebbia, C Giavoli, V Cappiello, ... The Journal of Clinical Endocrinology & Metabolism 89 (10), 5101-5104, 2004 | 131 | 2004 |
| The role of surgery in the management of recurrent adrenocortical carcinoma I Erdogan, T Deutschbein, C Jurowich, M Kroiss, C Ronchi, M Quinkler, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), 181-191, 2013 | 127 | 2013 |
| Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients V Cappiello, C Ronchi, PS Morpurgo, P Epaminonda, M Arosio, ... European Journal of Endocrinology 147 (2), 189-194, 2002 | 127 | 2002 |
| Recombinant Human GH Replacement Therapy and Thyroid Function in a Large Group of Adult GH-Deficient Patients: When Does l-T4 Therapy Become … S Porretti, C Giavoli, C Ronchi, G Lombardi, M Zaccaria, D Valle, M Arosio, ... The Journal of Clinical Endocrinology & Metabolism 87 (5), 2042-2045, 2002 | 126 | 2002 |
| Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept B Altieri, G Muscogiuri, L Barrea, C Mathieu, CV Vallone, L Mascitelli, ... Reviews in Endocrine and Metabolic Disorders 18 (3), 335-346, 2017 | 111 | 2017 |
| Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer A Berruti, M Fassnacht, H Haak, T Else, E Baudin, P Sperone, M Kroiss, ... European urology 65 (4), 832-838, 2014 | 95 | 2014 |
| Efficacy of a slow‐release formulation of lanreotide (Autogel® 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an … CL Ronchi, M Boschetti, ECD Uberti, S Mariotti, S Grottoli, P Loli, ... Clinical Endocrinology 67 (4), 512-519, 2007 | 90 | 2007 |
| Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors CL Ronchi, V Varca, P Beck-Peccoz, E Orsi, F Donadio, A Baccarelli, ... The Journal of Clinical Endocrinology & Metabolism 91 (1), 121-128, 2006 | 87 | 2006 |
| Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10‐year follow‐up study CL Ronchi, R Attanasio, E Verrua, R Cozzi, E Ferrante, P Loli, ... Clinical endocrinology 71 (6), 846-852, 2009 | 84 | 2009 |
| Effects of two different somatostatin analogs on glucose tolerance in acromegaly C Ronchi, P Epaminonda, V Cappiello, P Beck-Peccoz, M Arosio Journal of Endocrinological Investigation 25 (6), 502-507, 2002 | 77 | 2002 |
| Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy CL Ronchi, S Sbiera, L Kraus, S Wortmann, S Johanssen, P Adam, ... Endocrine-related cancer 16 (3), 907, 2009 | 70 | 2009 |
Martin FassnachtUniversitätsklinikum WürzburgVerified email at medizin.uni-wuerzburg.de
